Lineage Cell Therapeutics Inc. (NYSEAMERICAN: LCTX) Gains After FDA Gives Feedback On OPC1 IND

Lineage Cell Therapeutics Inc. (NYSEAMERICAN: LCTX) gained 2.16% after releasing an update in OPC1’s clinical development. OPC1 is the company’s experimental allogeneic oligodendrocyte progenitor cell (OPC) transplant therapy for spinal cord injury treatment.  Lineage receives FDA feedback on OPC1 IND Last week the company received feedback from the FDA under the US FDA’s Regenerative Medicine Advanced Therapy program. As a result, Lineage is planning to submit an amendment to its…

Read More >>

Lineage Cell Therapeutics Inc (NYSEAMERICAN: LCTX) Brings Onboard Kevin Cook To Serve As The Company’s Chief Financial Officer

Lineage Cell Therapeutics Inc (NYSEAMERICAN: LCTX) is quite pleased to make Kevin Cook its new Chief Financial Officer, effective June 21, 2021. It believes that the official will greatly contribute to its efforts to grow and become a top cell therapy and cell Transplant Company. The company considered Cook’s qualifications and track record The company chose Cook after considering the value he would bring to its business. That starts with his…

Read More >>

Borqs Technologies Inc (NASDAQ: BRQS) To Supply Android Based Handheld Computers To Several Markets

Borqs Technologies Inc (NASDAQ: BRQS) is set to supply Android-based handheld computers to the E.U., U.S., and Asian markets. The opportunity comes following the company’s successful landing of purchase orders from U.S. Fortune 500 Company.  Company’s operations Borqs hopes to channel in significant revenue streams with the development of rugged handheld computers. The company employs some key technologies in its manufacturing endeavors. It uses the integrated scanner and radio bands in…

Read More >>

World’s Debut 35,000-nit HRD Green OLED Microdisplay Produced Courtesy Kopin Corporation (NASDAQ: KOPN)

Kopin Corporation (NASDAQ: KOPN), a company that is regarded as one of the leading developers and provider of high-resolution micro-displays, display subassemblies, and systems, has in a statement made an official announcement that it has successfully produced what is called high-dynamic-range (HDR), green Organic Light Emitting Diode (OLED) microdisplay on silicon. The company is involved in developing and producing high-resolution microdisplays, display subassemblies, and systems used in various sectors, including…

Read More >>

Hop-On Inc (HPNN) Stock Consolidates After The Big Jump: What Next?

After the company made a major announcement with regards to its decentralized social media platform digitalage.com this morning, the Hop-On Inc (OTCMKTS:HPNN) stock has actually declined and gone down by 4%. However, at the same time, it is also necessary for investors to keep in mind that over the course of the past week the stock has clocked gains of as much as 60%. This morning the company announced that…

Read More >>

PharmaCyte Biotech (OTCMKTS:PMCB) Stock Extends Rally: Up 55% in a Week

In recent times, the PharmaCyte Biotech Inc (OTCMKTS:PMCB) stock has emerged as a notable gainer in the biotech space and the strong move has continued this morning. This morning the stock has carried on its momentum and soared by 13% to takes its gains for the past week to as much as 55%. Earlier today, the stock has come on to the radars of investors after it announced the steps…

Read More >>

RushNet Inc. (OTCMKTS: RSHN) Target heliosDX Collaborates with Verb Technology To Use verbLIVEand verbTEAMS

RushNet Inc. (OTCMKTS: RSHN), with acquisition/merger target heliosDX, has announced an upcoming launch of the National Sales Campaign using Verb Technology Company Inc. (NASDAQ: VERB) interactive marketing and sales platform.  heliosDX conducting national campaign to boost sales  heliosDX will undertake a national campaign to boost brand recognition and sales. verbTeams is the newest technology that enables companies to grow sales, close ratios, cut costs, and expand their reach nationwide. With…

Read More >>

Jounce Therapeutics Inc. (NASDAQ: JNCE) Receives IND Approval for JTX-1811 Licensed To Gilead, Shares Drop

Jounce Therapeutics Inc. (NASDAQ: JNCE) lost 2.55% after the FDA cleared its anti-CCR8 antibody, JTX-1811, Investigational New Drugs application for Gilead Sciences Inc. (NYSE: GILD) has rights to produce and market. The IND clearance will trigger a milestone payment of $25 million to Jounce.   Jounce developed JTX-1811  JTX-1811 is a monoclonal antibody developed by Jounce and intended to reduce immunosuppressive tumor-infiltrating T regulatory (TITR) cells exclusively. In Gilead’s pipeline, it…

Read More >>

Allied Energy Corp (OTCMKTS:AGYP) Rework Activities Starts at Two Lease Sites

Energy company Allied Energy Corp (OTCMKTS:AGYP) recently made an important announcement regarding their rework activities to two of their leasing sites. The energy company has scheduled workers to its Green Lease site and its Annie Gilmer site, according to the CEO of Allied Energy Corp George Montieth. The Green Lease site has cleared its wellsite location and built base pads for the brand new pumping units, as well as repairs…

Read More >>

Why Fleet Management Company Ultrack Systems Inc (OTCMKTS:MJLB) is Gaining Investor Interest

Demand for GPS fleet management is increasing rapidly due to increased government regulations, decreasing hardware and software costs, and the need for more cost effective fleet operating expenses. Because of this, research provider Global Market Insights projected the industry will hit $55 Billion by 2027. To provide some perspective, early estimates on the 2020 size of the market were around $7 Billion.  That would be a nearly $50 billion, or…

Read More >>
x